Clinical trials in cardiology are systematic investigations conducted to evaluate the safety, efficacy, and effectiveness of new treatments, interventions, or therapeutic strategies for cardiovascular conditions. These trials are essential for advancing medical knowledge, improving patient care, and informing evidence-based practices in cardiology. Various phases of clinical trials are conducted, starting with early-phase trials to assess safety and dosage, followed by larger, randomized controlled trials that aim to establish the efficacy of the intervention. Cardiology clinical trials often focus on diverse areas, including the development of new medications, evaluation of interventional procedures such as stent placement or cardiac surgeries, and investigation of innovative technologies like implantable devices. Participation in clinical trials allows patients access to cutting-edge treatments and contributes valuable data to the scientific community, shaping the future of cardiovascular medicine.
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya